Sleep+
Sleep+, licence 80109924: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Calm+, Deep Sleep, Easy Sleep, Restful Sleep, Restorative Sleep, Restore+, Simply Sleep, Sound Sleep
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80109924
- Status
- Active licence
- Licence date
- 14 May 2021
- Revision date
- 3 February 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Hydroxyde de magnésium | 50.0 mg | 100,000 µg |
| Ganoderma lucidum Source : Corps fructifère | 100.0 mg | Not calculated |
| Ganoderma lucidum Source : Cultured mycelium | 100.0 mg | Not calculated |
| L-théanine Source : Synthétique | 100.0 mg | Not calculated |
| Acide gamma-aminobutyrique Source : Acide 4-aminobutanoïque | 50.0 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 1.5 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Eau, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in tissue formation. Helps to maintain proper muscle function, including the heart muscle. Source of fungal polysaccharides with immunomodulating properties. Helps to temporarily promote relaxation. Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag). Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps to speed up/ reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/ with delayed sleep phase disorder.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80109924
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.